Esperion Therapeutics Inc... (ESPR)
0.95
-0.01 (-1.44%)
At close: Apr 17, 2025, 3:59 PM
0.96
0.76%
After-hours: Apr 17, 2025, 07:56 PM EDT
Esperion Therapeutics Revenue
Esperion Therapeutics reported an annual revenue of $332.31M, reflecting a 185.66% growth. For the quarter ending December 31, 2024, Esperion Therapeutics generated $69.11M in revenue.
Revenue (ttm)
$332.31M
Revenue Growth
185.66%
Price / Sales Ratio
1.24
Revenue / Employee
$1.09M
Employees
304
Market Cap
187.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 332.31M | +185.66% |
| Dec 31, 2023 | 116.33M | +54.14% |
| Dec 31, 2022 | 75.47M | -3.79% |
| Dec 31, 2021 | 78.45M | -65.52% |
| Dec 31, 2020 | 227.55M | n/a |